3-hydroxyflavone has been researched along with Parkinson Disease in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 4 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, J; Chang, SC; Ha, NC; Hong, DG; Kim, J; Lee, H; Lee, J; Lee, M; Lee, S; Yang, S | 1 |
| Cao, T; Guo, CH; Waddington, JL; Zhen, XC; Zheng, LT | 1 |
| Awasthi, A; Corrie, L; Kapoor, B; Kaur, J; Khurana, N; Khurana, S; Khursheed, R; Kumar, R; Sharma, N; Singh, SK; Verma, S; Vyas, M | 1 |
| Figueira, I; Fleming Outeiro, T; Godinho-Pereira, J; Marques, D; Menezes, R; Nunes Dos Santos, C; Rosado-Ramos, R | 1 |
| Maher, P | 1 |
| Jung, UJ; Kim, SR | 1 |
| Chen, X; Cheng, K; Cui, C; Jia, XB; Qiao, CM; Shen, YQ; Sun, MF; Xu, YD; Yang, XS; Zhang, PH; Zhou, ZL; Zhu, YL | 1 |
| Rajendran, M; Ramachandran, R | 1 |
| Chen, B; Cui, W; Jia, L; Liu, F; Lu, F; Sang, J; Wang, Y; Wei, W; Zhao, W | 1 |
| Braidy, N; Habtemariam, S; Manayi, A; Nabavi, SF; Nabavi, SM; Sureda, A | 1 |
| Cao, T; Ren, ZX; Zhao, YF; Zhen, XC | 1 |
| Ascherio, A; Cassidy, A; Gao, X; Rimm, EB; Schwarzschild, MA | 1 |
| Costa-Mallen, P; Hopkins, E; Renoudet, VV | 1 |
| Aruoma, OI; Datla, KP; Dexter, DT; Parkar, S; Rai, DK; Zbarsky, V | 1 |
3 review(s) available for 3-hydroxyflavone and Parkinson Disease
| Article | Year |
|---|---|
Protective effects of fisetin and other berry flavonoids in Parkinson's disease.
Topics: Animals; Brain; Flavonoids; Flavonols; Fruit; Humans; Parkinson Disease; Plant Extracts | 2017 |
Beneficial Effects of Flavonoids Against Parkinson's Disease.
Topics: Animals; Anthocyanins; Antioxidants; Antiparkinson Agents; Catechin; Cell Line; Corpus Striatum; Disease Models, Animal; Dopamine; Flavanones; Flavones; Flavonoids; Flavonols; Humans; Isoflavones; Kaempferols; Neuroprotective Agents; Oxidative Stress; Parkinson Disease | 2018 |
Neuroprotective Effects of Fisetin in Alzheimer's and Parkinson's Diseases: From Chemistry to Medicine.
Topics: Alzheimer Disease; Flavonoids; Flavonols; Humans; Molecular Structure; Neuroprotective Agents; Parkinson Disease | 2016 |
11 other study(ies) available for 3-hydroxyflavone and Parkinson Disease
| Article | Year |
|---|---|
Anti-Inflammatory and Neuroprotective Effects of Morin in an MPTP-Induced Parkinson's Disease Model.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Dopaminergic Neurons; Extracellular Signal-Regulated MAP Kinases; Flavones; Flavonols; Food Ingredients; Mice; Mice, Inbred C57BL; Microglia; MPTP Poisoning; Neuroprotective Agents; Parkinson Disease | 2022 |
Development and characterization of an inducible Dicer conditional knockout mouse model of Parkinson's disease: validation of the antiparkinsonian effects of a sigma-1 receptor agonist and dihydromyricetin.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; DEAD-box RNA Helicases; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Flavonols; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Morpholines; Oxidopamine; Parkinson Disease; Receptors, sigma; Ribonuclease III; Sigma-1 Receptor; Tamoxifen | 2020 |
Enhanced oral bioavailability and neuroprotective effect of fisetin through its SNEDDS against rotenone-induced Parkinson's disease rat model.
Topics: Administration, Oral; Animals; Biological Availability; Disease Models, Animal; Female; Flavonols; Neuroprotective Agents; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rotenone | 2020 |
Small Molecule Fisetin Modulates Alpha-Synuclein Aggregation.
Topics: alpha-Synuclein; Butyrates; Cell Line; Dopamine Plasma Membrane Transport Proteins; Flavonols; Humans; Models, Biological; Oxidative Stress; Parkinson Disease; Piperidines; Protein Aggregates; Saccharomyces cerevisiae; tert-Butylhydroperoxide | 2021 |
Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Astrocytes; Disease Models, Animal; Dopaminergic Neurons; Down-Regulation; Flavonols; Humans; Male; Mice; Mice, Inbred C57BL; Microglia; Motor Activity; MPTP Poisoning; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Phosphatidylinositol 3-Kinases; Substantia Nigra | 2019 |
Fisetin protects against rotenone-induced neurotoxicity through signaling pathway.
Topics: Antioxidants; Apoptosis; Blotting, Western; Cell Line, Tumor; Down-Regulation; Flavonoids; Flavonols; Humans; Lipid Peroxidation; Neuroblastoma; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Rotenone; Signal Transduction | 2019 |
Dihydromyricetin Inhibits α-Synuclein Aggregation, Disrupts Preformed Fibrils, and Protects Neuronal Cells in Culture against Amyloid-Induced Cytotoxicity.
Topics: alpha-Synuclein; Ampelopsis; Amyloid beta-Peptides; Animals; Apoptosis; Drugs, Chinese Herbal; Flavonols; Humans; Hydrophobic and Hydrophilic Interactions; Neurons; Neuroprotective Agents; Parkinson Disease; PC12 Cells; Protein Aggregates; Rats | 2019 |
Dihydromyricetin protects neurons in an MPTP-induced model of Parkinson's disease by suppressing glycogen synthase kinase-3 beta activity.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Line; Flavonols; Glycogen Synthase Kinase 3 beta; Male; Mice, Inbred C57BL; Neuroprotective Agents; Parkinson Disease; Protein Kinase Inhibitors; Rats | 2016 |
Habitual intake of dietary flavonoids and risk of Parkinson disease.
Topics: Adult; Aged; Anthocyanins; Beverages; Citrus sinensis; Confounding Factors, Epidemiologic; Feeding Behavior; Female; Flavanones; Flavones; Flavonoids; Flavonols; Follow-Up Studies; Fruit; Health Personnel; Humans; Incidence; Male; Malus; Middle Aged; Odds Ratio; Parkinson Disease; Prospective Studies; Risk Assessment; Surveys and Questionnaires; Tea; Wine | 2012 |
A diet low in animal fat and rich in N-hexacosanol and fisetin is effective in reducing symptoms of Parkinson's disease.
Topics: Animals; Dietary Fats; Fatty Alcohols; Female; Flavonoids; Flavonols; Humans; Middle Aged; Parkinson Disease; Treatment Outcome | 2012 |
Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Curcumin; Disease Models, Animal; Dopamine; Flavanones; Flavonoids; Flavonols; Homovanillic Acid; Male; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Phenols; Quercetin; Rats; Rats, Sprague-Dawley; Tyrosine 3-Monooxygenase | 2005 |